Effectiveness of Short-Acting Opioid Escalation vs Initiation of a Long-Acting Opioid in Nursing Home Residents.

Pain and mood assessments were taken from quarterly administrative records rather than immediate post-change evaluations, creating a median delay of 41 days between the regimen change and outcome measurement. The study relied on medication dispensing claims, so it could not verify that residents actually received or took the prescribed opioids. Residents who discontinued new regimens early due to side effects or lack of effectiveness were excluded, which may overestimate how well the treatments worked. Pain and mood data included both self-reports and staff assessments, which introduces potential measurement error, especially for residents with cognitive impairment.

One author is a consultant for Exponent, and another is a consultant for Optum Epidemiology. The study was supported by non-U.S. government and NIH extramural research grants.

Do not conclude that long-acting opioids are ineffective or unsafe. The study showed comparable outcomes between short-acting escalation and long-acting initiation, but it did not test whether higher doses or different opioid combinations might provide better relief for residents whose pain remains uncontrolled.